He-Cheng Huang

428 total citations
22 papers, 275 citations indexed

About

He-Cheng Huang is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, He-Cheng Huang has authored 22 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in He-Cheng Huang's work include Esophageal Cancer Research and Treatment (12 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). He-Cheng Huang is often cited by papers focused on Esophageal Cancer Research and Treatment (12 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). He-Cheng Huang collaborates with scholars based in China, United States and Austria. He-Cheng Huang's co-authors include He-San Luo, Sheng‐Xi Wu, Li‐Yan Xu, Ze-Sen Du, En‐Min Li, Xiu‐E Xu, Lian‐Di Liao, Xiumei Cai, Wan‐Wan Lin and Jianjun Zhang and has published in prestigious journals such as Scientific Reports, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

He-Cheng Huang

20 papers receiving 273 citations

Peers

He-Cheng Huang
Johanna Jesche Austria
Viktoria Stühler Germany
Hideaki KURIOKA Japan
Dezuo Dong China
Fu-Zhi Ji China
Yue‐Feng Wen China
Alessandra Bologna Italy
Xiaoluan Yan China
Feilong Yang China
Yingsheng Wen China
Johanna Jesche Austria
He-Cheng Huang
Citations per year, relative to He-Cheng Huang He-Cheng Huang (= 1×) peers Johanna Jesche

Countries citing papers authored by He-Cheng Huang

Since Specialization
Citations

This map shows the geographic impact of He-Cheng Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by He-Cheng Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites He-Cheng Huang more than expected).

Fields of papers citing papers by He-Cheng Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by He-Cheng Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by He-Cheng Huang. The network helps show where He-Cheng Huang may publish in the future.

Co-authorship network of co-authors of He-Cheng Huang

This figure shows the co-authorship network connecting the top 25 collaborators of He-Cheng Huang. A scholar is included among the top collaborators of He-Cheng Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with He-Cheng Huang. He-Cheng Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Wenzhi, He-Cheng Huang, Guanghui Zhu, et al.. (2025). Serum multiomics prediction of prognosis and adverse reactions to concurrent chemoradiotherapy in patients with esophageal cancer. British Journal of Cancer. 133(12). 1829–1843. 1 indexed citations
2.
Liu, Wei, Wenzhi Wu, Xiu‐E Xu, et al.. (2024). Construction and validation of classification models for predicting the response to concurrent chemo-radiotherapy of patients with esophageal squamous cell carcinoma based on multi-omics data. Clinics and Research in Hepatology and Gastroenterology. 48(4). 102318–102318. 3 indexed citations
3.
Liu, Luxin, Xiu‐E Xu, Lian‐Di Liao, et al.. (2023). Acetyl-CoA Acetyltransferase 2 Confers Radioresistance by Inhibiting Ferroptosis in Esophageal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 117(4). 966–978. 11 indexed citations
4.
Xu, Xiu‐E, Lian‐Di Liao, Wan‐Wan Lin, et al.. (2022). Cisplatin-induced pyroptosis is mediated via the CAPN1/CAPN2-BAK/BAX-caspase-9-caspase-3-GSDME axis in esophageal cancer. Chemico-Biological Interactions. 361. 109967–109967. 41 indexed citations
5.
Luo, He-San, Yung‐Ming Chen, Weizhen Huang, et al.. (2021). Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer. Radiation Oncology. 16(1). 201–201. 26 indexed citations
6.
Luo, Wei, Ying Huang, Yang Chen, et al.. (2021). STAT3β Enhances Sensitivity to Concurrent Chemoradiotherapy by Inducing Cellular Necroptosis in Esophageal Squamous Cell Carcinoma. Cancers. 13(4). 901–901. 20 indexed citations
7.
8.
Zhang, Xiaoxian, He-Cheng Huang, Yuanyuan Yu, et al.. (2020). Impact of whey protein isolate and eccentric training on quadriceps mass and strength in patients with anterior cruciate ligament rupture: A randomized controlled trial. Journal of Rehabilitation Medicine. 52(3). 0–0.
9.
Huang, He-Cheng, et al.. (2020). CypA: A Potential Target of Tumor Radiotherapy and/or Chemotherapy. Current Medicinal Chemistry. 28(19). 3787–3802. 11 indexed citations
10.
11.
12.
13.
Cai, Xiumei, et al.. (2018). The efficacy of concurrent weekly carboplatin with radiotherapy in the treatment of cervical cancer: A meta-analysis. Gynecologic Oncology. 150(3). 412–419. 19 indexed citations
14.
15.
Chen, Jinghong, et al.. (2018). Efficacy of Stereotactic Body Radiotherapy for Recurrent or Residual Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization. BioMed Research International. 2018. 1–6. 6 indexed citations
16.
Wu, Sheng‐Xi, et al.. (2017). Effect of consolidation chemotherapy following definitive chemoradiotherapy in patients with esophageal squamous cell cancer. Scientific Reports. 7(1). 16870–16870. 13 indexed citations
17.
Yang, Li, He-Cheng Huang, Long-Qi Chen, et al.. (2017). Predictive biomarkers for response of esophageal cancer to chemo(radio)therapy: A systematic review and meta-analysis. Surgical Oncology. 26(4). 460–472. 16 indexed citations
18.
Tao, Xu, Bojin Su, Chun‐Hua Wang, et al.. (2015). Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinoma. Oncology Reports. 33(3). 1418–1426. 15 indexed citations
19.
Huang, He-Cheng, et al.. (2006). [Expressions and correlation with radiotherapy's effect of five kinds of genes in nasopharyngeal carcinoma].. PubMed. 41(7). 542–5. 1 indexed citations
20.
Huang, He-Cheng, et al.. (2004). [Expression and correlation with metastasis of E-cadherin, CD44H, matrix metalloproteinase-3, nm23H1 and VEGF in nasopharyngeal carcinoma].. PubMed. 18(8). 470–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johanna Jesche Breakdown of academic impact, for papers by Viktoria Stühler Breakdown of academic impact, for papers by Hideaki KURIOKA Breakdown of academic impact, for papers by Dezuo Dong Breakdown of academic impact, for papers by Fu-Zhi Ji Breakdown of academic impact, for papers by Yue‐Feng Wen Breakdown of academic impact, for papers by Alessandra Bologna Breakdown of academic impact, for papers by Xiaoluan Yan Breakdown of academic impact, for papers by Feilong Yang Breakdown of academic impact, for papers by Yingsheng Wen
Rankless by CCL
2026